NPI: 1124261854 · HUNTINGTON PARK, CA 90255 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,500 | $2.72M |
| 2019 | 12,558 | $1.63M |
| 2020 | 18,811 | $2.08M |
| 2021 | 26,495 | $2.86M |
| 2022 | 18,212 | $2.58M |
| 2023 | 16,846 | $2.92M |
| 2024 | 15,803 | $2.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 50,995 | 5,222 | $11.05M |
| 0821 | 4,672 | 1,241 | $4.46M | |
| Z6004 | 745 | 622 | $956K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,107 | 2,796 | $468K |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,498 | 1,881 | $199K |
| J1756 | Injection, iron sucrose, 1 mg | 9,168 | 2,621 | $96K |
| A4657 | Syringe, with or without needle, each | 9,345 | 1,980 | $28K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,151 | 659 | $23K |
| 90674 | 168 | 165 | $3K | |
| 90662 | 99 | 99 | $2K | |
| 0250 | 3,587 | 205 | $2K | |
| 83970 | 862 | 848 | $1K | |
| G0008 | Administration of influenza virus vaccine | 65 | 64 | $336.48 |
| 85041 | 795 | 767 | $108.69 | |
| 85048 | 803 | 774 | $92.32 | |
| 82728 | 351 | 335 | $56.70 | |
| 83550 | 309 | 288 | $31.08 | |
| 83540 | 373 | 348 | $12.23 | |
| 82108 | 82 | 79 | $6.44 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 28 | 22 | $0.00 |
| 0302 | 22 | 19 | $0.00 |